Association between ICS therapy for COPD and diabetes onset and progression

Conclusions: Long-term, high-dose ICS therapy for COPD is associated with an increased risk of diabetes onset and progression.

Source: European Respiratory Journal - November 19, 2018 Category: Respiratory Medicine Authors: Voorham, J., Roche, N., Stephens, J., Park, H. Y., Fogel, R., Clemens, A., Brusselle, G., Price, D. Tags: Clinical Problems Source Type: research